Defining rare diseases in China
Author:
Affiliation:
1. Shandong Academy of Medical Science, Shandong Medical Biotechnological Center, Key Laboratory for Biotech Drugs of the Ministry of Health
Publisher
International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)
Subject
General Medicine
Link
https://www.jstage.jst.go.jp/article/irdr/6/2/6_2017.01009/_pdf
Reference5 articles.
1. 1. Han J, Cui Y, Zhou X. Rare diseases research in China: Opportunities, challenges, and solutions. Intractable Rare Dis Res. 2012; 1:10-12.
2. 2. Wang JB, Guo JJ, Yang L, Zhang YD, Sun ZQ, Zhang YJ. Rare diseases and legislation in China. Lancet. 2010; 375:708-709.
3. 3. Zhao H, Cui Y, Zhou X, Pang J, Zhang X, Xu S, Han J. Study and analysis of the state of rare disease research in Shandong Province, China. Intractable Rare Dis Res. 2012; 1:161-166.
4. 4. Song P, Gao J, Inagaki Y, Kokudo N, Tang W. Rare diseases, orphan drugs, and their regulation in Asia: Current status and future perspectives. Intractable Rare Dis Res. 2012; 1:3-9.
5. 5. Cui Y, Han J. A proposed definition of rare diseases for China: From the perspective of return on investment in new orphan drugs. Orphanet J Rare Dis. 2015; 10:28.
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Long-term distress throughout one’s life: health-related quality of life, economic and caregiver burden of patients with neurofibromatosis type 1 in China;Frontiers in Public Health;2024-08-21
2. How will the public health committees develop after COVID-19 pandemic in China? Exploration from mixed methods study in Pingshan District, Shenzhen;Frontiers in Public Health;2024-01-17
3. Is sub-national healthcare social protection sufficient for protecting rare disease patients? the case of China;Frontiers in Public Health;2023-06-16
4. Trend of drug clinical trials in mainland China from 2009 to 2020;Current Medical Research and Opinion;2022-07-29
5. National Rare Diseases Registry System (NRDRS): China’s first nation-wide rare diseases demographic analyses;Orphanet Journal of Rare Diseases;2021-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3